Learn the latest findings from several studies and organizations, including the Centers for Disease Control and Prevention’s Epidemiology of Pneumonia in the Community study, U.S. Food and Drug Administration, Inner City Asthma Consortium, National Heart, Lung, and Blood Institute’s Division of Lung Diseases Specialized Centers of Clinically Oriented Research Program, and the COPDGene study. All sessions are from noon to 1 p.m.

Wednesday
L21: Community-Acquired Pneumonia in Adults: Results from the CDC-EPIC Study
Room 204 A-B (200 Level) Pennsylvania Convention Center

L22: Pulmonary Update from the U.S. Food and Drug Administration
Room 201 A-B (200 Level) Pennsylvania Convention Center

L23: Inner City and Asthma: An Insight to the Disease
Room 103 B-C (100 Level) Pennsylvania Convention Center

L24: Occupational Respiratory Hazards in Health Care
Room 113 B-C (100 Level) Pennsylvania Convention Center

L25: Update on the Phase II Trials in the NHLBI DLD Specialized Centers of Clinically Oriented Research Program
Room 120 A-B-C (100 Level) Pennsylvania Convention Center

L26: An Update on the COPDGene Study: Progress and Future Plans
Room 121 A-B-C (100 Level) Pennsylvania Convention Center

Please see the Final Program for speaker information.